Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer

Seisuke Inada,Takashi Tomidokoro,Hiroyuki Fukunari,Tomomi Sato,Toru Hatano,Atsushi Nishimura,Yasuyuki Kawauchi,Keiya Nikkuni,Takeaki Shimizu,Toshiteru Sato,Masahiko Yanagi,Satoru Takahashi,Hideki Yoshida,Minoru Sugita,Tetsuji Hayashi

Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer

2009

Seisuke Inada
Takashi Tomidokoro
Hiroyuki Fukunari
Tomomi Sato
Toru Hatano
Atsushi Nishimura
Yasuyuki Kawauchi
Keiya Nikkuni
Takeaki Shimizu
Toshiteru Sato
Masahiko Yanagi
Satoru Takahashi
Hideki Yoshida
Minoru Sugita
Tetsuji Hayashi

Purpose We aimed to examine the safety and antitumor effects of a combination of S-1 and paclitaxel in patients with unresectable or recurrent gastric cancer in a phase I/II setting.

Keywords:

Recurrent gastric cancer
Clinical trial
Oncology
Pharmacology
Maximum tolerated dose
Combination therapy
Paclitaxel
Medicine
Internal medicine
Adverse effect
Toxicity
Discontinuation
Regimen
Nausea
Neutropenia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations